Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease.
Rodriguez-Roisin R, Tetzlaff K, Watz H, Wouters EF, Disse B, Finnigan H, Magnussen H, Calverley PM. Rodriguez-Roisin R, et al. Among authors: tetzlaff k. Int J Chron Obstruct Pulmon Dis. 2016 Aug 22;11:1973-81. doi: 10.2147/COPD.S106142. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27578972 Free PMC article. Clinical Trial.
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
Watz H, Tetzlaff K, Wouters EF, Kirsten A, Magnussen H, Rodriguez-Roisin R, Vogelmeier C, Fabbri LM, Chanez P, Dahl R, Disse B, Finnigan H, Calverley PM. Watz H, et al. Among authors: tetzlaff k. Lancet Respir Med. 2016 May;4(5):390-8. doi: 10.1016/S2213-2600(16)00100-4. Epub 2016 Apr 7. Lancet Respir Med. 2016. PMID: 27066739 Clinical Trial.
Determinants of exacerbation risk in patients with COPD in the TIOSPIR study.
Calverley PM, Tetzlaff K, Dusser D, Wise RA, Mueller A, Metzdorf N, Anzueto A. Calverley PM, et al. Among authors: tetzlaff k. Int J Chron Obstruct Pulmon Dis. 2017 Nov 29;12:3391-3405. doi: 10.2147/COPD.S145814. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 29238184 Free PMC article. Clinical Trial.
Withdrawal of inhaled glucocorticoids and exacerbations of COPD.
Magnussen H, Disse B, Rodriguez-Roisin R, Kirsten A, Watz H, Tetzlaff K, Towse L, Finnigan H, Dahl R, Decramer M, Chanez P, Wouters EF, Calverley PM; WISDOM Investigators. Magnussen H, et al. Among authors: tetzlaff k. N Engl J Med. 2014 Oct 2;371(14):1285-94. doi: 10.1056/NEJMoa1407154. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25196117 Free article. Clinical Trial.
Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment.
Hall IP, Fowler AV, Gupta A, Tetzlaff K, Nivens MC, Sarno M, Finnigan HA, Bateman ED, Rand Sutherland E. Hall IP, et al. Among authors: tetzlaff k. Pulm Pharmacol Ther. 2015 Jun;32:37-44. doi: 10.1016/j.pupt.2015.03.003. Epub 2015 Apr 8. Pulm Pharmacol Ther. 2015. PMID: 25861737 Free article. Clinical Trial.
127 results